From Tyler, Texas, USA:
I am a diabetes educator studying for my CDE exam for October 2006. The blood sugar goals, as recommended by the ADA for fasting is 90 to 130 mg/dl [5.0 to 7.2 mmol/L]. Has it always been at this range? I thought it was 80 to 120 mg/dl [4.4 to 6.7 mmol/L], but recent ADA recommendations state the former. I am aware that the American Association of Clinical Endocrinologists (AACE) has stricter guidelines for blood sugar control. My patients often ask about why ADA guidelines are higher.
It's a long story. When the original meters came out, they measured whole blood. Now, they measure plasma, which is 10 to 15% higher than whole blood. So, the ADA changed to match the change in the meters. AACE took the opportunity to lower the recommended values by not changing.
It really doesn't matter in practice. Now, we think more about a target glucose and then do corrections based on that target....at least I do and most do with the pumps. I use 120 mg/dl [6.7 mmol/L] as the target for most, but 150 mg/d [8.3 mmol/L] for my youngest patients, within the guidelines for children from ADA. Most importantly, if we get patients to either of the targets, the diabetes control will be spectacular, the A1c great and complications prevented. This is all splitting hairs as the average A1c in America is well over 8.0. Only 5% of patients have glucose, blood pressure and lipids controlled.
Original posting 31 Jul 2006
Posted to Other
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:10:08
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.